ASDAS high disease activity versus BASDAI elevation in patients with ankylosing spondylitis as selection criterion for anti-TNF therapy Nathan Vastesaeger, Bert Vander Cruyssen, Juan Mulero, Jordi Gratacós Masmitjá, Pedro Zarco, Raquel Almodovar, Pilar Font, Xavier Juanola, Eduardo Collantes-Estevez

Comparison of disease activity in patients with ankylosing spondylitis under TNFi or NSAID treatment, is there any difference? An observational study Mireia Moreno, Marta Arévalo, Marc Zamora, Caridad Pontes, Juan Carlos Oliva, Jordi Gratacós

Evaluation of thiol-disulfide homeostasis in active ankylosing spondylitis patients Medeni Arpa, Bayram Şen, Münevver Serdaroğlu Beyazal, Özcan Erel